Massachusetts Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
486,632
-15,391
| -3% | -$560K | 0.01% | 630 |
|
|
2025
Q1 | $18.2M | Buy |
502,023
+1,306
| +0.3% | +$47.3K | 0.01% | 605 |
|
|
2024
Q4 | $21.1M | Sell |
500,717
-41,656
| -8% | -$1.75M | 0.01% | 594 |
|
|
2024
Q3 | $30.1M | Buy |
542,373
+172,126
| +46% | +$9.56M | 0.01% | 536 |
|
|
2024
Q2 | $15.2M | Buy |
370,247
+103,280
| +39% | +$4.24M | ﹤0.01% | 603 |
|
|
2024
Q1 | $12.5M | Buy |
+266,967
| New | +$12.5M | ﹤0.01% | 609 |
|